N.J. High Court Concludes Risperdal/Seroquel/Zyprexa Multicounty Litigation
November 4, 2021
DOCUMENTS
- Notice to the Bar
TRENTON, N.J. — The New Jersey Supreme Courts has concluded the Risperdal/Seroquel/Zyprexa state court multicounty litigation, according to a recent notice to the bar.
In the Nov. 1 notice, the court explained that it sought comments on the recommendation of Superior Court Judge Bruce Kaplan for conclusion of the MCL litigation and received no comments objecting to the proposal.
The New Jersey Supreme Court designated all New Jersey state court litigation involving the drugs to Middlesex County Superior Court in September 2006 and they are presently assigned to Judge Bruce Kaplan. The court found the cases meet the requirements …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach